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Delivery of sedation in anticipation of weaning of adult patients from prolonged mechanical ventilation is an arena
of critical care medicine where opinion-based practice is currently hard to avoid because robust evidence is lacking.
We offer some views on this subject, hoping to stimulate debate among colleagues.
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Although even brief scrutiny of MEDLINE and
ClinicalTrials.gov reveals that vigour and ingenuity
are being directed towards evaluating every aspect of in-
tensive care unit (ICU) medicine, it remains the case that
a comprehensive base of evidence is not available for every
aspect of practice. In the absence of conclusive evidence,
well-founded opinions retain a role in providing a frame-
work for clinical reasoning and decision making.
Whether and how to deliver sedation in anticipation
of weaning of adult patients from prolonged mechanical
ventilation is one arena where such opinion-based medi-
cine is called for as new methods and resources emerge,
as the limitations of some established practices are better
appreciated and as we wait for a new generation of ran-
domized controlled trials (RCTs) to provide definitive evi-
dence. In this paper we offer some views on this subject,
hoping to stimulate debate among colleagues.
Issues for consideration in this context include:
(1) Definition of weaning and the distribution of
weaning experience
(2) Aspects of current practice that should be discarded
(3) Criteria for weaning
(4) Influence of the type/quality of sedation on the
success/failure of weaning in ICU patients* Correspondence: g.conti@rm.unicatt.it
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unless otherwise stated.(5) Weaning in the context of cooperative sedation
(a concept unknown when several pivotal RCTs on
weaning were performed).
Defining weaning
Weaning is the liberation of a patient from mechanical
ventilatory support. As such it is a process not an outcome
and a process that starts when the decision is taken to in-
tubate a patient. Weaning is thus not the same thing as
extubation; rather, extubation may be seen as the culmin-
ation of the weaning process.
Maintaining patients on the weaning pathway requires
a holistic approach that prioritizes the best preservation
of respiratory muscles without excessive stress to patients,
maintenance of haemodynamic stability, nutrition and
electrolyte status, and attention to patient’s motivation
and engagement.
A corollary of this definition of weaning is that non-
invasive ventilation (NIV) can be an important and valuable
part of the weaning process and an adjunct to extubation.
This is demonstrably the case in chronic obstructive
pulmonary disease (COPD), as shown in several RCTs
[1-3]. NIV is often applied in non-COPD cases of
hypoxaemic respiratory failure, though as yet without
the substantiation of major RCTs [4,5].
The distribution of weaning experience
The general pattern of weaning described by Boles et al. [6]
remains a broadly accurate summary of routine experi-
ence. Thus some 70% of mechanically ventilated patientstd. This is an Open Access article distributed under the terms of the Creative
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remaining 30%, about 25% experience ‘difficult’ weaning
(defined as failure the first time but success within 1 week
of the first attempt) and 5% experience prolonged weaning
(defined as >1 week with repeated attempts).
The confirmation by the Spanish Lung Failure
Collaborative Group that ventilator support can be
successfully discontinued in two-thirds of ventilated
patients after a 2-h spontaneous breathing trial (SBT)
is also compatible with this distribution [7].
Aspects of current practice that should be discarded
Three elements of what might be termed the classic
weaning schedule are either unnecessary or redundant
and should be discarded.
Predictors of weaning
None of the claimed predictors of weaning, whether used
alone or in combination, are reliably predictive of weaning
success and no time or effort should be wasted on monitor-
ing them for that purpose. This lack of reliability is evident
for unitary criteria such as vital capacity, maximal in-
spiratory pressure and minute ventilation [8-10] and
for the respiratory frequency to tidal volume (f/VT) ra-
tio [11], which at one time seemed the most promising
practical predictive instrument.
The spontaneous awakening trial
The adoption by ICUs (certainly in Europe) of awake,
cooperative sedation as the standard of care means that
the spontaneous awakening trial [12] is now largely an
anachronism, relevant only to those narrow sectors of
the ICU population where deep sedation is still needed
(e.g. traumatic brain injury [TBI] or acute respiratory
distress syndrome [ARDS] patients or those receiving
neuromuscular blockers [NMBs]). Outside those areas,
few ICU patients are too ill to be awake with sedation
provided proper attention is given to their needs for
analgesia.
Early tracheotomy
Given that some 70% of patients can expect to be
weaned successfully at the first attempt, there is no ar-
gument for a generalized use of early tracheotomy as a
prelude or adjunct to weaning [13,14]. There may be
exceptions to that verdict for brain-injured patients or
multiple trauma victims.
Criteria for weaning
The central question in weaning is when to complete the
return to unsupported spontaneous breathing. Readiness
should be monitored by ‘dynamic assessment’, anchored
by a series of key considerations that emphasize trend and
stability, rather than by rigid thresholds.1. Resolution of the underlying cause of acute
respiratory failure
2. Haemodynamic stability, defined as no need for
vasoactive/inotropic drugs
3. Adequate neurological status, defined as:
Glasgow Coma Scale score >8a or, if sedated, target
Richmond Agitation-Sedation Scale score in the
range −2 to 0 achieved with minimal sedation
4. Preferably absence of fever (defined as
temperature <38°C)b
5. Adequate gas exchange, as indicated by a partial
pressure of oxygen:fraction of inspired oxygen
ratio >200 with a positive end-expiratory pressure
of 5 cmH2O
6. Partial pressure of carbon dioxide adjusted to bring
blood pH into the normal range [7].
Weaning in the context of cooperative sedation
Current guidelines on weaning rest very considerably on
the findings of RCTs performed during the last decade
of the 20th century. One of those studies demonstrated
that immediate extubation after a successful SBT accel-
erates weaning and reduces the duration of mechanical
ventilation [7]. Two other studies showed that the ability
to breathe spontaneously can be adequately tested by a
trial with either T-tube or pressure support of 7 cmH2O
lasting either 30 or 120 min [15]. Two randomized studies
found that synchronized intermittent mandatory ventila-
tion is the worst method of weaning in difficult-to-wean
patients [7,16].
However, all those studies required patients to be
sedative-free before weaning was attempted. That was
a reasonable stipulation given the nature of the seda-
tives and the sedation protocols then prevailing. In
view of the current widespread emphasis on coopera-
tive sedation - a concept undeveloped at the time of
those trials - and the increased availability of sedatives
free from adverse effects on respiration, there is an evi-
dent need for new studies analysing the effects of these
new sedation paradigms on the weaning process.
Until such studies are completed, the evidence base
for the optimized management of weaning is incomplete.
However, it is possible to propose a framework of guidance
for current practice.
 Most patients who require sedation in the context of
weaning are likely to be among the 30% or so of
patients not weaned successfully at the first attempt.
Ongoing sedation in the context of weaning will thus
be confined most likely to a minority of patients.
 ‘Sedation’ should be described and configured as
‘analgo-sedation’. This word highlights the primacy
of pain relief for the delivery of patient comfort
before, during and after weaning.
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and should be regarded in any case as the default
target in the absence of special circumstances such
as severe ARDS, TBI or use of NMBs.
 Use of longer-acting sedatives should be avoided.
There should be, in particular, a strong presumption
against the use of benzodiazepines, which ought
now to be regarded as drugs of last resort in most
situations. This latter conclusion is aligned with and
draws support from the recent retrospective analyses
of Fraser et al. [17].
 Rapid or abrupt termination of an established
sedative regimen should be avoided, especially when
longer-acting sedatives have been used.
 Step-down sedation, for example substituting propofol
for a benzodiazepine, may be needed for patients who
have been maintained on longer-acting agents.
 Monitoring of minimally sedated awake, cooperative
patients for pain, agitation and delirium (both hyper-
and hypo-active) should be systematically conducted
at least once a day as part of the weaning routine.
(This need not take very long.) When detected, the
first response must be to correct the primary cause,
not to obscure it with sedation. The general principles
and practical guidance enumerated by Barr and
colleagues [18] provide the basis for current best
practice in this area, but it should be noted that many
of those recommendations are based on limited
evidence, especially in the area of ICU delirium.
 Identification and effective treatment of pain is a
priority, including pain as the cause of agitation.
Delirium (in whatever form) is often associated with
pain or agitation and in these cases it will likely
respond to measures to relieve pain and agitation.
We concur with Barr et al. [18] in regarding the
Confusion Assessment Method for The Intensive
Care Unit and the Intensive Care Delirium Screening
Checklist as currently the best instruments for
identification of delirium, combining practicability
with reliability and accuracy (see also Neto et al. [19]).
(It is again important to note that at the time when
some major RCTs on weaning were performed, even
the concept of ‘delirium’ was poorly described and
not incorporated in the decision analysis.)
 The long-term impact of delirium on the trajectory
of an ICU patient remains a matter of debate, but a
growing body of evidence supports the assertion that
delirium is associated with impaired post-ICU
cognitive function [20]. There is more certainty
about its adverse impact on the patient’s course in the
ICU and in particular on the duration of mechanical
ventilation. Attention to delirium is thus an essential
feature of preparations for weaning, including all
aspects of sedation practice. Barr et al. [18] identifycontinuous infusion of dexmedetomidine as the only
pharmacological measure likely to reduce the duration
of delirium.
 Because many patients who need sedation as an
adjunct to weaning will have experienced prolonged
or difficult weaning, effects of sedatives on respiratory
function are an important consideration.
 Sedatives that act via γ-aminobutyric acid
(GABA)-ergic pathways (e.g., benzodiazepines,
opioids and propofol) adversely affect respira-
tory drive and/or timing. This aspect is very im-
portant, as sedation with GABA-ergic and/or
morphine-like agents can represent per se a source
of patient–ventilator asynchrony, prolonging the
need for ventilatory support [21].
 Alpha2-agonists do not adversely affect
respiratory drive and/or timing.
A range of sedative regimens are in use in Europe,
reflecting differing circumstances, priorities or perspec-
tives at national or sub-national levels. It is, therefore,
infeasible to recommend a single agent or regimen, but
for patients undergoing difficult or prolonged weaning
there should be a presumption in favour of short-acting
sedatives delivered as a continuous infusion. Remifentanil
and dexmedetomidine are particularly well suited to that
requirement and can be relied on to deliver comfort to
patients emerging into spontaneous breathing while also
meeting the goal of minimal/awake sedation. Low-dose
morphine in the manner advocated by Strøm et al. [22]
may also be considered, though there is a widespread
assumption (not yet formally tested) that this approach
requires a very low (probably 1:1) staff:patient ratio to
enable it to be implemented consistently successfully.
Remifentanil should be used as a very low-dose continu-
ous infusion (e.g. 0.05 μg/kg/min) to avoid possible adverse
effects on respiration [23].
Dexmedetomidine appears to be particularly well
suited to the needs of patients receiving NIV as part of
a step-down ventilation strategy or for the prevention
(but not treatment) of post-extubation weaning failure.
One rationale for this application is that NIV enables
some patients to be extubated sooner than might be
possible if they were being restored directly from
mechanically supported to fully unsupported breath-
ing. Patients proceeding to NIV may, therefore, be
extubated sooner and/or at a deeper level of sedation
than if they were being restored to unsupported breathing.
Dexmedetomidine-based sedation during NIV may,
therefore, be used as a step-down measure replacing
longer-acting sedatives and to prepare the patient for
the final phase of weaning by establishing conscious
sedation, just as NIV itself is used as a step-down ven-
tilation measure prior to extubation.
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that the evidence from randomized trials of the benefit of
NIV as an aid to weaning or to prevent post-extubation
failure is substantially limited to acute-on-chronic respira-
tory failure, most obviously COPD. Whether or not using
NIV under present conditions reflects this limitation and
whether an emphasis on newer sedatives such as dexmede-
tomidine might enhance the success of NIV in this context
or expand the range of valid clinical situations in which NIV
is advantageous are matters deserving of early investigation.
Other situations in which dexmedetomidine is strongly
to be favoured include:
 Patients at risk for weaning syndrome and/or
delirium, or otherwise vulnerable to mental
deterioration for non-organic reasons
 Patients experiencing sleep deprivation. (Dosages
may be adjusted throughout the 24-h cycle to help
restore a more normal sleep–wake pattern, in the
wider context of measures to promote/protect sleep.
Though inter alia see Tamrat et al. [26] for a recent
systematic review of non-pharmacological measures
to promote sleep. The broad conclusion of that work
is that there is a lack of good-quality evidence to
guide practice in this arena.)
Conclusions
The time has probably come to revisit all aspects of
weaning and weaning protocols in view of recent trans-
formation in sedative practice for critically ill patients [18].
Considering the interrelation between sedation and wean-
ing it is increasingly difficult to justify persisting with prac-
tice based on experience and conclusions derived from
sedation studies performed with drugs that possess im-
portant pharmacological drawbacks and which increas-
ingly are regarded as seldom appropriate except as agents
of last resort in an era when little if any use was made of
sedation scales and when the significance (or even exist-
ence) of delirium was greatly under-appreciated and
formed no part of clinical reasoning or procedure.
It is time that the evidence base for sedation and
weaning was enlarged to reflect the new realities already
in force in many countries. In the short term there
should be a concerted effort to address the many areas
of practice where the authors of the pain, agitation, and
delirium (PAD) guidelines [18] could find either no evi-
dence better than grade C or no evidence at all. As a
longer-term strategy we propose that research should
aim to provide evidential support for all recommenda-
tions of the 2013 PAD guidelines to at least level 1B.
Endnotes
aWeaning success rates in TBI and neurocritical patients
are not always nil. This implies that the minimum level ofconsciousness required for successful weaning may be
lower than is generally acknowledged; however, these data
do not justify accepting worse than the best achievable level
of awareness in non-TBI patients. bTemperature >38°C
is not an absolute barrier if the fever is of non-infectious
origin. In such cases, the delay implied in waiting several
days for temperature to fall below 38°C may itself be an
outcome worth trying to avoid.
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